×
About 22,485 results

ALLMedicine™ Herpes Center

Research & Reviews  7,273 results

Improving Shingles Vaccination Rates in Family Medicine.
https://doi.org/10.12788/jfp.0218
The Journal of Family Practice; Luther JS

Aug 26th, 2021 - At the end of the activity, participants will be able to: • Characterize the burden of herpes zoster infections. • Recommend the recombinant zoster vaccine to patients in accordance with guidance from the Advisory Committee on Immunization Practic...

HSV-1 small non-coding RNA (sncRNA) 1 and 2 activate the Herpes virus entry mediator (H...
https://doi.org/10.1128/JVI.01985-21
Journal of Virology; Tormanen K, Wang S et. al.

Dec 2nd, 2021 - HSV-1 latency associated transcript (LAT) plays a significant role in efficient establishment of latency and reactivation. LAT has antiapoptotic activity and downregulates expression of components of the Type I interferon pathway. LAT also specifi...

Baricitinib demonstrates consistent long-term safety profile in RA
https://www.mdedge.com/rheumatology/article/249281/rheumatoid-arthritis/baricitinib-demonstrates-consistent-long-term

Dec 1st, 2021 - Key clinical point: Baricitinib maintained a stable safety profile with no new safety signals even with long-term exposure of up to 9. 3 years in patients with active rheumatoid arthritis (RA).

Acyclovir-Resistant Cutaneous Herpes Simplex Virus in DOCK8 Deficiency.
https://doi.org/10.12788/cutis.0364
Cutis Hopkins CR, Lowe N et. al.

Dec 1st, 2021 - Patients with dedicator of cytokinesis 8 (DOCK8) deficiency are susceptible to development of severe viral cutaneous infections, including herpes simplex virus (HSV). We report a 32-month-old girl with homozygous DOCK8 deficiency who developed a p...

HSV-encephalitis Resembling Acute Cerebral Infarction in a Patient With Atrial Fibrilla...
https://doi.org/10.1097/NRL.0000000000000353
The Neurologist; Kargiotis O, Oikonomi K et. al.

Nov 30th, 2021 - Herpes simplex virus-1 (HSV-1) encephalitis, the most common and potentially life-threatening type of encephalitis, may rarely present as a stroke mimic. Prompt diagnosis is of paramount importance for the timely initiation of antiviral treatment ...

see more →

Guidelines  17 results

Vaccines for measles, mumps, rubella, varicella, and herpes zoster: immunization guidel...
https://www.ncbi.nlm.nih.gov/pubmed/22086887
The Journal of the American Osteopathic Association; Hendriksz T, Malouf P et. al.

Dec 7th, 2011 - Although vaccinations are most commonly associated with the pediatric population, it is important for healthcare professionals to be familiar with the vaccines that are recommended for adults. The authors discuss 3 vaccines-the measles, mumps, and...

Management of Genital Herpes in Pregnancy: ACOG Practice Bulletinacog Practice Bulletin...
https://doi.org/10.1097/AOG.0000000000003840
Obstetrics and Gynecology;

Apr 26th, 2020 - Genital herpes simplex virus (HSV) infection during pregnancy poses a risk to the developing fetus and newborn. Genital herpes is common in the United States. Among 14- to 49-year-old females, the prevalence of HSV-2 infection is 15.9%. However, t...

Management of Genital Herpes in Pregnancy: ACOG Practice Bulletin Summary, Number 220.
https://doi.org/10.1097/AOG.0000000000003841
Obstetrics and Gynecology Reference;

Apr 26th, 2020 - Genital herpes simplex virus (HSV) infection during pregnancy poses a risk to the developing fetus and newborn. Genital herpes is common in the United States. Among 14- to 49-year-old females, the prevalence of HSV-2 infection is 15.9%. However, t...

Antimicrobial Prophylaxis for Adult Patients With Cancer-Related Immunosuppression: ASC...
https://doi.org/10.1200/JCO.18.00374
Journal of Clinical Oncology : Official Journal of the Am... Taplitz RA, Kennedy EB et. al.

Sep 5th, 2018 - To provide an updated joint ASCO/Infectious Diseases Society of America (IDSA) guideline on antimicrobial prophylaxis for adult patients with immunosuppression associated with cancer and its treatment. ASCO and IDSA convened an update Expert Panel...

No. 208-Guidelines for the Management of Herpes Simplex Virus in Pregnancy.
https://doi.org/10.1016/j.jogc.2017.04.016
Journal of Obstetrics and Gynaecology Canada : JOGC = Jou... Money DM, Steben M

Jul 22nd, 2017 - To provide recommendations for the management of genital herpes infection in women who want to get pregnant or are pregnant and for the management of genital herpes in pregnancy and strategies to prevent transmission to the infant. More effective ...

see more →

Drugs  608 results see all →

Clinicaltrials.gov  200 results

Pilot Study of Reduced-Intensity Hematopoietic Stem Cell Transplant of DOCK8 Deficiency
https://clinicaltrials.gov/ct2/show/NCT01176006

Nov 24th, 2021 - Background Mutations in the Dedicator of Cytokinesis-8 (DOCK8) gene are responsible for an immunodeficiency disease characterized by: severe cutaneous and sinopulmonary infections with bacterial organisms; extensive cutaneous viral infections with...

PREVENT-COVID-19: A Q-Griffithsin Intranasal Spray
https://clinicaltrials.gov/ct2/show/NCT05122260

Nov 16th, 2021 - Q-Griffithsin (Q-GRFT) nasal spray is an investigational product that has broad spectrum antiviral activity. Q-GRFT is derived from Griffithsin (GRFT) a naturally occurring protein originally isolated from the red alga Griffithsia found in the Sou...

Trial on Efficacy and Safety of Pritelivir Tablets for Treatment of Acyclovir-resistant Mucocutaneous HSV (Herpes Simplex Virus) Infections in Immunocompromised Subjects
https://clinicaltrials.gov/ct2/show/NCT03073967

Nov 15th, 2021 - The trial comprises 5 Parts, Part A, B, C, D and E. Part A and Part B (Phase 2) have been closed in November 2020. Part A is a randomized, open-label, multi-center, comparative design to assess the efficacy and safety in subjects with ACV-resistan...

Comparison of Foscarnet Versus Vidarabine in the Treatment of Herpes Infection in Patients With AIDS Who Have Not Had Success With Acyclovir
https://clinicaltrials.gov/ct2/show/NCT00000985

Nov 4th, 2021 - Foscarnet is a drug that inhibits viruses and has been shown to be effective against infection with Cytomegalovirus and also against infection with the Herpes simplex virus in several patients with AIDS. Vidarabine has been shown to have activity ...

Foscarnet Treatment of Serious CMV Retinitis Infection in Patients With Acquired Immunodeficiency Syndrome
https://clinicaltrials.gov/ct2/show/NCT00000726

Nov 3rd, 2021 - Foscarnet is active in vitro (test tube) against herpes viruses, including CMV, by inhibiting the virus DNA polymerases, enzymes necessary for virus replication, without affecting cellular DNA polymerases. Opportunistic CMV disease in AIDS is usua...

see more →

News  860 results

Baricitinib demonstrates consistent long-term safety profile in RA
https://www.mdedge.com/rheumatology/article/249281/rheumatoid-arthritis/baricitinib-demonstrates-consistent-long-term

Dec 1st, 2021 - Key clinical point: Baricitinib maintained a stable safety profile with no new safety signals even with long-term exposure of up to 9. 3 years in patients with active rheumatoid arthritis (RA).

Atopic Dermatitis and the Risk of Infections
https://www.medscape.com/viewarticle/962913

Nov 14th, 2021 - Takeaway Atopic dermatitis (AD) was associated with an increased risk of hospitalised infections, opportunistic infections and several herpesvirus infections in both children and adults, with the risk being greatest in those with severe skin disea...

Slight Increase in Risk of Guillain-Barre After Recombinant Zoster Vaccine Confirmed
https://www.medscape.com/viewarticle/962005

Nov 2nd, 2021 - NEW YORK (Reuters Health) - An analysis of Medicare claims data found an increased risk of Guillain-Barre syndrome (GBS) following receipt of the recombinant zoster vaccine (RZV), confirming the same "signal" from the U.S. Centers for Disease Cont...

Guillain-Barre Risk Up Slightly After Shingrix
https://www.medpagetoday.com/neurology/generalneurology/95364

Nov 1st, 2021 - Risk of Guillain-Barré syndrome (GBS) increased slightly after receiving the recombinant zoster vaccine (RZV; Shingrix), Medicare claims data showed. In the 42 days after vaccination, researchers found approximately three excess GBS cases per mill...

Upadacitinib Shows Potential for Ulcerative Colitis
https://www.medscape.com/viewarticle/961553

Oct 25th, 2021 - LAS VEGAS, Nevada — An oral Janus kinase 1 (JAK1) inhibitor upadacitinib (Rinvoq, AbbVie) showed high efficacy and good safety as a treatment for ulcerative colitis in a phase 3 trial. The finding could provide some reassurance after the US Food a...

see more →

Patient Education  36 results see all →